International directory enquiries <a href=" http://www.litecom.ch/buy-flomaxtra.pdf#dry ">tamsulosin hcl ranbaxy capsule mga 0.4 mg</a> China’s top economic planning agency is investigating the costs and prices of drugmakers including Glaxo, Merck, Novartis and Baxter International Inc. (BAX) to improve the pricing system for medicines. The National Development and Reform Commission will examine 27 companies for costs and 33 for pricing, according to a July 2 statement.